The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.
November 19th 2024
Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with type 2 diabetes in the Blood Pressure Control Target in Diabetes trial.
November 14th 2024
November 5th 2024
Dr Robert Gabbay on COVID-19 Vaccinations in the Diabetes Community
FDA Grants Empagliflozin Breakthrough Therapy Designation in HFpEF